Nerve Repair and Regeneration Market Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2027
The global Nerve Repair and Regeneration Market will be worth USD 11.62 Billion by 2027, according to a current analysis by Emergen Research. The growth of this market can be attributed to the rising incidence of spinal injuries among the geriatric population. The increasing need for the technological advancements of the existing treatment methods for neurological disorders in order to enhance the efficiency of the treatment methods is expected to drive the growth of the Nerve Repair and Regeneration Market over the forecast period. The increasing prevalence of neurodegenerative diseases, such as Parkinson's disease, Alzheimer’s disease, multiple sclerosis, and epilepsy, is a key contributing factor to the growing demand for nerve repair and regeneration products. The launch of the enhanced and technologically advanced product by the major industry players is expected to fuel the growth of the market.
Key Highlights
From The Report
In 2019, Medtronic launched the Intellis platform for the
management of certain types of chronic intractable pain. The platform was
designed to overcome limitations with current spinal cord stimulation (SCS)
systems, such as battery performance, and power the Evolve workflow. It can
track patients 24/7 and help in monitoring chronic pain.
The Neurostimulation and Neuromodulation Devices segment
held the largest market share of 59.4% in 2019. The increasing incidence of
spinal injuries is expected to increase the demand for spinal cord stimulation
devices and drive the growth of the Neurostimulation and Neuromodulation
Devices.
Stem Cell Therapy is forecasted to grow with the fastest
CAGR of 9.7% over the forecast period. Increasing brain and spinal cord injury,
neurodegeneration, frailty syndrome, and heart diseases have increased the
adoption of stem cell therapies.
The Asia Pacific region is expected to be the
fastest-growing region over the forecast period due to the supportive
government initiatives to improve the healthcare infrastructure and increase
healthcare budgetary allocation.
Key
participants include Abbott Laboratories, Medtronic, Plc, Boston
Scientific Corporation, BAXTER INTERNATIONAL, INC., LIVANOVA, PLC., AXOGEN,
INC., Stryker Corporation, Cyberonics, Inc., INTEGRA LIFESCIENCES, and SOTERIX
MEDICAL, INC., among others.
Regional
scope- North America; Europe; Asia Pacific; Central & South
America; MEA
Product
Outlook (Revenue, USD Billion; 2017-2027)
Neurostimulation and Neuromodulation Devices (Sacral Nerve,
Spinal Cord, Vagus Nerve, Gastric Electric, and Deep Brain Stimulation Devices)
Biomaterial
Surgery
Outlook (Revenue, USD Billion; 2017-2027)
Stem Cell Therapy
Direct Nerve Repair
Nerve Grafting
Neurostimulation and Neuromodulation Surgeries
Comments
Post a Comment